C Trl Therapeutics Appoints Derrell D. Porter, M.D., As Chief Executive Officer
Nov 01, 2023•over 1 year ago
Position
Chief Executive Officer
Company
CTRL Therapeutics
Description
cTRL Therapeutics, a biotechnology company harnessing circulating tumor-reactive lymphocytes in the blood to broaden the power and reach of solid tumor cell therapy to more patients, today announced the appointment of Derrell D. Porter, M.D., as Chief Executive Officer.
FundzWatch™ Score
22
Medium Activity
3 total signals
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months